Coherus completes Surface Oncology acquisition, files Surface's financials on 8-K/A

Coherus Oncology, Inc.

Merger closed Sep 8, 2023; Surface became wholly owned subsidiary after two-step merger.
Unaudited condensed financial statements of Surface for H1 2023 and 2022 now filed on this amendment.
Financial statements incorporated from Surface's Q2 2023 10-Q filed Aug 2, 2023.
Original 8-K filed Sep 8, 2023 reported the closing; this amendment adds required financials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.